GoodRx Holdings, Inc. - Common Stock (GDRX)

Historical Holders from Q1 2019 to Q3 2025

Symbol: GDRX on Nasdaq
Type / Class: Equity / Common Stock
Shares outstanding: 98,685,316
All holders as of 30 Sep 2025: Q3 2025
Total 13F shares, excl. options: 117,310,573
Holdings value: $496,189,440
% of all portfolios: 0.003%
Number of holders: 154
Number of buys: 70
Number of sells: -107
Average buys %: +0%
Average sells %: -0%

Reported Shares, Excluding Options vs Price

Reported Value, Excluding Options

Total Investors

Significant Owners of GoodRx Holdings, Inc. - Common Stock (GDRX)

Filer	Ownership	Change %	Holdings Value	Net Change	Nb Shares	Change %	Reporting Name	Report Period
FRANCISCO PARTNERS IV, L.P.	36%		$288,375,283		60,078,184		Francisco Partners GP IV, L.P.	16 Mar 2025
Idea Men, LLC	29.1%	-10%	$207,188,021	-$33,600,000	43,164,171	-14%	Idea Men, LLC	21 Mar 2025
VANGUARD GROUP INC	9.33%		$38,947,048		9,207,340		The Vanguard Group	30 Sep 2025
Bezdek Trevor	5.2%		$25,881,571		5,391,994		Trevor Bezdek	16 Dec 2024
Hirsch Douglas Joseph	5.2%		$25,881,571		5,391,994		Douglas Joseph Hirsch	16 Dec 2024
AMERIPRISE FINANCIAL INC	4.3%		$22,246,901		4,634,771		Ameriprise Financial, Inc.	31 Mar 2025
MILLENNIUM MANAGEMENT LLC	2.1%		$10,496,971		2,186,869		Millennium Management LLC	31 Dec 2024

Institutional Holders of GoodRx Holdings, Inc. - Common Stock (GDRX)

Period	Reported Shares, Excl. Options	Value, Excl. Options	Change	Puts Notional Value	Calls Notional Value	Price	Investors
2025 Q3	117,310,573	$496,189,440	-$16,473,431	$779,937	$1,132,599	$4.23	154
2025 Q2	120,458,255	$599,884,035	-$4,664,396	$1,072,568	$2,632,048	$4.98	176
2025 Q1	121,628,630	$536,393,039	-$65,698,797	$1,033,218	$2,331,576	$4.41	164
2024 Q4	135,968,354	$632,244,381	-$55,086,685	$1,083,997	$3,405,278	$4.65	164
2024 Q3	142,032,675	$985,856,098	+$68,387,395	$3,667,096	$5,016,926	$6.94	163
2024 Q2	131,725,500	$1,027,464,544	+$24,275,288	$5,045,820	$4,648,800	$7.8	161
2024 Q1	128,743,736	$913,896,618	-$90,749,328	$2,238,630	$3,006,850	$7.1	154
2023 Q4	141,637,249	$948,962,237	+$31,081,244	$3,505,440	$3,181,830	$6.7	138
2023 Q3	137,728,416	$775,404,583	+$22,462,538	$2,858,351	$2,913,525	$5.63	151
2023 Q2	133,773,340	$738,443,895	-$18,174,990	$1,103,875	$2,069,070	$5.52	142
2023 Q1	136,443,326	$852,764,205	+$5,540,468	$1,652,500	$2,190,000	$6.25	151
2022 Q4	135,872,173	$633,174,025	-$16,390,175	$2,630,370	$3,649,128	$4.66	153
2022 Q3	139,523,504	$651,663,220	-$76,552,465	$2,299,700	$4,347,934	$4.67	156
2022 Q2	154,602,951	$915,568,088	-$34,966,903	$1,766,000	$6,410,000	$5.92	152
2022 Q1	145,985,292	$2,821,832,723	-$467,032,693	$34,331,559	$31,478,939	$19.33	158
2021 Q4	152,652,179	$4,988,313,146	+$336,547,280	$66,389,056	$37,123,000	$32.68	203
2021 Q3	139,573,202	$5,725,100,634	-$84,091,429	$151,666,300	$98,465,000	$41.02	208
2021 Q2	57,223,135	$2,060,732,372	+$355,935,810	$125,058,150	$72,601,000	$36.01	190
2021 Q1	131,712,129	$5,139,356,421	+$168,916,078	$124,109,300	$48,599,000	$39.02	196
2020 Q4	127,079,191	$5,131,253,891	+$41,105,714	$60,410,000	$28,455,000	$40.34	184
2020 Q3	36,851,110	$2,049,308,578	+$2,048,509,583	$3,147,000	$667,000	$55.6	144
2020 Q2	2,367	$85,000				$35.91	1
2020 Q1	2,367	$85,000				$35.91	1
2019 Q4	2,367	$85,000				$35.91	1
2019 Q3	2,367	$85,000				$35.91	1
2019 Q2	2,367	$85,000				$35.91	1
2019 Q1	2,367	$85,000				$35.91	1